Guardant Health
GH
#3260
Rank
$3.59 B
Marketcap
$29.11
Share price
-3.64%
Change (1 day)
30.19%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: $3.59 Billion USD

As of November 2024 Guardant Health has a market cap of $3.59 Billion USD. This makes Guardant Health the world's 3260th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024$3.59 B9.54%
2023$3.28 B17.84%
2022$2.78 B-72.6%
2021$10.16 B-21.09%
2020$12.88 B75.59%
2019$7.33 B127.64%
2018$3.22 B

End of Day market cap according to different sources

On Nov 16th, 2024 the market cap of Guardant Health was reported to be:

$3.59 Billion USD
by Nasdaq info icon info icon
$3.59 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$19.28 B 436.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.16 B-12.04%๐Ÿ‡บ๐Ÿ‡ธ USA